Resolution Bioscience, a part of Agilent, is pioneering next generation cancer diagnostics that enable physicians to tailor treatments for each patient using only a blood test — a liquid biopsy. Our proprietary molecular analytics platform interrogates cell-free DNA for actionable information that, until now, has only been accessible through invasive biopsy procedures.
We have developed over 50 focused panels and are currently working on companion diagnostics to support therapeutic approvals.
We are dedicated to improving cancer outcomes through a suite of clinical tests to guide selection of targeted therapies and monitor their effectiveness over time.
|
|
|
|
|
11-50 employees
View all Resolution Bioscience employees
|
|
|
Biotechnology Research
|
|
|
$10M–$50M
|
|
|
(206) 258-3000
|
|
|
550 Kirkland Way, Suite 200, Kirkland, WA 98033, US
|
|
|
2012
|
|
|
Cancer Diagnostics, Genetics, Molecular Biology, Next Generation Sequencing, Cell Free Dna, Cfdna, Circulating Biomarkers, Ngs Technology, Liquid Biopsy, Ivd, Ctdna, Cdx, Liquidbiopsy
|
The decision makers in Resolution Bioscience are Celine Ngouenet, Eric Gagne, Kavita Garg, etc. Click to Find Resolution Bioscience decision makers emails.
Resolution Bioscience headquarters is located at 550 Kirkland Way, Suite 200, Kirkland, WA 98033, US.
Resolution Bioscience generates an estimated $10M–$50M annually, based on industry analysis and publicly available market data.
You can contact Resolution Bioscience by calling (206) 258-3000.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.